Organ Preservation Market is poised to value over USD 300 million by 2028 end at a CAGR of over 6.3% during the forecast period 2022 to 2028.

Organ preservation is the ability to preserve ex vivo organ viability as well as to restore normal organ function when blood flow is restored. It is the supply line for organ transplantation. For patients with end-stage disease, organ transplantation is the most effective treatment.  In the process of transplanting an organ, the required organ is removed from the donor's body, then stored and transported. Depending on the requirements, the organ is normally washed with a preservation solution and stored according to its specific preservation needs. Providing preservation solutions and techniques is vital to donor organ quality, which directly impacts morbidity and survival after transplantation.

The most frequent cold storage solution in organ preservation is the UW solution. Originally developed for pancreatic transplantation, it has been widely used to preserve various organs, including the kidney, liver, and bowel. This intracellular preservation solution has low sodium and high potassium concentrations to mimic intracellular conditions.Celsior is a type of extracellular preservation solution used to preserve cardiac grafts in cold storage. Currently, the method is used to preserve the heart, lungs, liver, pancreas, kidneys, and small bowels. Celsior is a low-potassium, high-sodium solution. In addition to the above solutions, there are numerous other solutions used for cold storage preservation of organs. The composition of each solution may vary, but the key strategy is similar: minimize ischemic/hypoxic injury and maximize organ function after reperfusion using colloids, impermeants, electrolytes, antioxidants, and nutrients.

Clinically, delayed graft function (DGF) or primary nonfunction (PNF) occur when an organ doesn't recover quickly from implantation surgery and reperfusion. By definition, delayed graft function is impaired function that returns to normal over time. Alternatively, graft PNF indicates that the organ will not be able to function or survive. A growing number of chronic diseases and organ failures among the world's population has increased the need for organ preservation. Growing geriatric population has pushed up market demand. Smoking, drinking, and other lifestyle choices have led to the development of organ failure, as well as an increase in the need to preserve organs at the end of life.

A report published by FutureWise Market Research provides an in-depth analysis of Organ Preservation Market trends that will impact the market's growth. Additionally, it contains detailed information on the profitability graph, SWOT analysis, market share, and regional expansion of this business. In addition, this report offers information on the current position of prominent market players in the competitive landscape analysis of this market.

By the end of the forecast period, the Organ Preservation Market is predicted to achieve substantial growth, according to a research study conducted by FutureWise research analysts. In the report, it is explained that this industry is predicted to exhibit a noteworthy growth rate. The report includes highly detailed information about the current market valuation as well as the segmentation of this industry as well as the growth opportunities within this business niche.

Major players included in the Organ Preservation Market:

  • Bristol-myers Squibb
  • Xvivo Perfusion AB
  • Paragonix Technologies
  • Franz Kohler Chemie Gmbh
  • Biolife Solutions Inc.
  • Claris Lifesciences Limited 
  • Lifeline Scientific
  • Tolerotech Inc.
  • 21st Century Medicine
  • Cryolife Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Organ Preservation Market Segmentation:

By Solution

  • University of Wisconsin (UW)
  • Custodial HTK
  • Perfadex
  • Others (Celsior & Euro-Collins)

By Technique

  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion

By Organ Type

  • Kidneys
  • Liver
  • Lung
  • Heart
  • Others (Intestine & Pancreas)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Organ Preservation Market Sample Video:

Competitive Landscape:

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

Objectives of the Study:

  • To provide with an exhaustive analysis on the Organ Preservation Market By Solution, By Technique, By Organ Type and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics